Largest biotech companies by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech companies ranked by total debt, at NOK 529.6B, ahead of Gilead Sciences (NOK 241.9B) and Biogen (NOK 61B). Figures as of 18 Nov 2026, 19:59 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenNOK 529.6B
Median
NOK 5.7B
Combined market value
NOK 8.13T
Countries
5
Not ranked
13no total debt on file

Market values as of .

All countries
All sectors
Biotech
NOK
Clear filters
Largest biotech companies by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNOK 529.6BNOK 2.33TNOK 4,303.99 3.10% down 34% up United States
2Gilead SciencesGILD · Health CareNOK 241.9BNOK 2.04TNOK 1,641.03 0.63% down 33% up United States
3BiogenBIIB · Health CareNOK 61BNOK 358.9BNOK 2,427.84 0.19% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareNOK 20.8BNOK 106.5BNOK 934.34 0.38% up 37% up United States
5QiagenQGEN · Health CareNOK 16BNOK 99.3BNOK 480.94 0.33% down 12% up Netherlands
6ModernaMRNA · Health CareNOK 5.7BNOK 779.8BNOK 1,927.16 3.92% down 755% up United States
7RepligenRGEN · Health CareNOK 5.3BNOK 106.6BNOK 1,667.03 5.97% up 5% up United States
8Bio-TechneTECH · Health CareNOK 1.9BNOK 110.9BNOK 705.92 0.21% up 26% up United States
9Adaptive BiotechnologiesADPT · Health CareNOK 1.3BNOK 44.7BNOK 276.24 0.04% down 88% up United States
10Scholar Rock HoldingSRRK · Health CareNOK 967.1MNOK 56.6BNOK 464.21 6.17% up 14% up United States
11CG OncologyCGON · Health CareNOK 29.1MNOK 69.3BNOK 776.09 1.36% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6994 NOK). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies rank first by total debt?

Amgen (NOK 529.6B), Gilead Sciences (NOK 241.9B) and Biogen (NOK 61B) are the top three of the 11 biotech companies ranked by total debt as of 18 Nov 2026, 19:59 UTC.

How many biotech companies are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 11 biotech companies ranked by total debt have a combined market value of NOK 8.13T as of 18 Nov 2026, 19:59 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.